Gaudium IVF and Women Health IPO opens: Check Day 1 subscription, price band, lot size and more

Gaudium IVF and Women Health IPO: The initial public offering of fertility services provider Gaudium IVF and Women Health Limited opened for subscription on Friday, February 20. The issue will conclude on February 24. The price band has been fixed at ₹75 to ₹79 per share.

The ₹165 crore initial share sale is a mix of new equity shares valued at ₹90 crore and an offer for sale of ₹75 crore by promoter Dr Manika Khanna.

Proceeds from the fresh issue will be utilised to set up 19 new IVF centres across the country, along with repayment of debt and for general corporate purposes.

Gaudium IVF and Women Health IPO Day 1: Subscription status

The issue has been subscribed 68% so far on Friday, the first day of bidding. It got bids for 98,96,040 shares against 1,46,20,340 shares on offer, according to the BSE data until 2:22 pm.

Prior to the IPO, the company collected ₹49.5 crore from anchor investors, including MERU Investment Fund PCC-CELL, Hornbill Orchid India Fund, Carnelian India Multi Strategy Fund and Sanshi Fund I. The company allocated 62,65,860 equity shares to these investors at ₹79 apiece.

Gaudium IVF and Women Health IPO: Lot size

A lot consists of 189 shares. Half of the net offer is reserved for qualified institutional buyers, 35% for retail individual investors and 15% for non-institutional investors.

Gaudium IVF and Women Health IPO: Allotment and listing date

Founded by Khanna, Gaudium IVF has solidified its position as a pioneer in assisted reproductive technologies in India. It operates through a hub-and-spoke model, with seven hubs (centers) and 28 spokes across multiple states, allowing it to reach a wide patient base.

Gaudium IVF intends to expand into underserved regions by offering affordable IVF services, leveraging the brand recognition associated with its founder.

On the financial front, the company reported revenue from operations of ₹70.72 crore and a net profit of ₹19.13 crore for the financial year ending March 31, 2025. In FY24, revenue stood at ₹47.89 crore, with a post-tax profit of ₹10.31 crore.

Gaudium IVF and Women Health IPO GMP

According to investorgain.com and media reports, Gaudium IVF's unlisted shares are trading at ₹87.5, reflecting a grey market premium (GMP) of 10.76% over the upper price band of ₹79.